Target intelligence / Profile preview

Anxiolytic

Molecular classification
Other
01

Overview

"Anxiolytic" refers broadly to any substance or drug that reduces anxiety. It is *not* itself a molecule or biological target but rather describes an effect produced by diverse classes of medications acting through different mechanisms. The most common anxiolytics are benzodiazepines—which enhance GABAergic inhibition via positive allosteric modulation at GABA-A receptors—and certain antidepressants like SSRIs/SNRIs that increase serotonergic neurotransmission. Some agents act directly on specific subtypes of serotonin receptors. Because "anxiolytic" denotes an action rather than an entity, it cannot be mapped to one canonical structure or abbreviation; instead, it encompasses multiple pharmacological strategies targeting different proteins within neural circuits regulating fear and stress responses.[1][3][5][7]

Other names
Anti-anxiety agentTranquilizerMinor tranquilizer
02

Mechanism of action

Drugs with anxiolytic effects act via several mechanisms:\n- Positive allosteric modulation of GABA-A receptors by benzodiazepines and barbiturates increases inhibitory neurotransmission in the CNS[1][3][7].\n- Inhibition of serotonin reuptake by SSRIs/SNRIs increases synaptic serotonin levels in key brain regions involved in mood regulation[5].\n- Direct agonism at certain serotonin receptors (e.g., buspirone at the serotonin 1A receptor)[7].

03

Biological functions

Other
04

Disease associations

Neuropsychiatric disordersAnxiety disorders
05

Safety considerations

Sedation/drowsinessDependence/addiction potential especially for benzodiazepines and barbituratesWithdrawal symptoms upon discontinuationCognitive impairment with long-term use
06

Interacting drugs

Benzodiazepines (e.g., alprazolam/Xanax, lorazepam/Ativan)

4 more in the full profile.

Beyond the preview

Go deeper on Anxiolytic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anxiolytic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call